RxDoctor Payments Data

Brenda Ewart, DO

Family Medicine · Flower Mound, TXNPI 1285747030

Payments from drug & device makers

$1,058in general payments, 2019–2025

Across 61 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$180
  • AbbVie$154
  • GSK$99
  • Exact Sciences$93
  • Boehringer Ingelheim$88
  • Sanofi-aventis U.S. LLC$80
  • plus $363 from 11 others

What the payments were for

  • Food & beverage$1,058100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,058 in reported general payments places this provider in the 60th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$68,963
Medicare patients
191
Services billed
1,005

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$79,897
JardianceEmpagliflozin51$77,021
MounjaroTirzepatide16$37,596
TrulicityDulaglutide11$20,555
RybelsusSemaglutide11$17,091
Breo ElliptaFluticasone/Vilanterol31$13,898
FarxigaDapagliflozin Propanediol12$11,972
Spiriva RespimatTiotropium Bromide12$6,557
Atorvastatin Calcium415$3,944
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$3,789
Rosuvastatin Calcium339$3,510
Levothyroxine Sodium255$2,665
SynthroidLevothyroxine Sodium43$2,484
Metoprolol Succinate151$2,178
Desvenlafaxine Succinate ErDesvenlafaxine Succinate20$1,814

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$49$96,98853 claims
Boehringer IngelheimJardiance, Spiriva Respimat$88$83,57863 claims
Lilly USA, LLCMounjaro, Trulicity$180$58,15127 claims
GSKBreo Ellipta$99$13,89831 claims
AstraZenecaFarxiga$51$11,97212 claims
AbbVieSynthroid$154$2,48443 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Flower Mound

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →